Abrotanum
- Manufacturer
- Hahnemann Laboratories, Inc.
- Effective date
- 2025-01-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 9
- Source
- full-release
- Hydrated at
- 2026-06-01 02:30:32
Label at a glance#
ProductAbrotanum
Active ingredientARTEMISIA ABROTANUM FLOWERING TOP
Label structure1 sections
Label contents#
Full prescribing information#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63545-711-04 | 2022-07-27 | C162847 | 48780-1 | ba0f9c33-356d-a910-e053-dadaa90a0b85 | 99ee837b-c8ff-9ca2-e053-2995a90af6f4 |
| 63545-711-04 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-356d-a910-e053-dadaa90a0b85 | 99ee837b-c8ff-9ca2-e053-2995a90af6f4 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63545-711-04 | Abrotanum | 10000 in 1 BOTTLE, GLASS | PELLET | 10000 | 9 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Abrotanum
- ARTEMISIA ABROTANUM FLOWERING TOP
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 63545-711 | 63545-711-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARTEMISIA ABROTANUM FLOWERING TOP | QG07G580U0 | ACTIB |
| SUCROSE | C151H8M554 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99ecc4da-37c2-5031-e053-2a95a90acc8c | 2025-01-09 | 63545-711 | |
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99ed12d2-f323-0840-e053-2a95a90a40ff | 2025-01-09 | 63545-711 | |
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99ee837b-c8ff-9ca2-e053-2995a90af6f4 | 2025-01-09 | 63545-711-04 63545-711 63545071104 2b4a2c07-24cd-ac03-e063-6394a90a3535 99ee837b-c8ff-9ca2-e053-2995a90af6f4 | |
| Abrotanum | ABROTANUM | Hahnemann Laboratories, Inc. | 99ebfabe-7c78-1732-e053-2a95a90aaced | 2025-01-09 | 63545-711 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
